Suppression of E1A-mediated transformation by the p50E4F transcription factor

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 4739-4749

  Fernandes, Elma R ^a,c   Rooney, Robert J ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN 3T3; CELL TRANSFORMATION; GENE EXPRESSION; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0033038707     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.4739     Document Type: Article

References (80)

1. Alevizopoulos, K., B. Catarin, J. Vlach, and B. Amati. 1998. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1). EMBO J. 17:5987-5997.
2. Attardi, L. D., S. W. Lowe, J. Brugarolas, and T. Jacks. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:3693-3701.
3. Boyd, J. M., T. Subramanian, U. Schaeper, M. La Regina, S. Bayley, and G. Chinnadurai. 1993. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12:469-478.
4. Chen, H., and M. C. Hung. 1997. Involvement of co-activator p300 in the transcriptional regulation of the HER-2/neu gene. J. Biol. Chem. 272:6101-6104.
5. Chen, H., D. Yu, G. Chinnadurai, D. Karunagaran, and M. C. Hung. 1997. Mapping of adenovirus 5 E1A domains responsible for suppression of neumediated transformation via transcriptional repression of neu. Oncogene 14:1965-1971.
6. Chinnadurai, G. 1992. Adenovirus E1a as a tumor-suppressor gene. Oncogene 7:1255-1258.
7. Chiou, S. K., and E. White. 1997. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71:3515-3525.
8. Condorelli, G., and A. Giordano. 1997. Synergistic role of E1A-binding proteins and tissue-specific factors in differentiation. J. Cell Biochem. 67: 423-431.
9. Cone, R. D., T. Grodzicker, and M. Jaramillo. 1998. A retrovirus expressing the 12S adenoviral E1A gene product can immortalize epithelial cells from a broad range of rat tissues. Mol. Biol. Cell 8:1036-1044.
10. Darzynkiewicz, Z., E. Bedner, F. Traganos, and T. Murakami. 1998. Critical aspects in the analysis of apoptosis and necrosis. Hum. Cell 11:3-12.
11. Darzynkiewicz, Z., G. Juan, X. Li, W. Gorczyca, T. Murakami, and F. Traganos. 1997. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1-20.
12. Datto, M. B., P. P. Hu, T. F. Kowalik, J. Yingling, and X. F. Wang. 1997. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17:2030-2037.
13. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
14. Decaudin, D., S. Geley, T. Hirsch, M. Catedo, P. Marchetti, A. Macho, R. Kofler, and G. Kroemer. 1997. Bcl-2 and Bel-XL antagonize the mitochrondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:62-67.
15. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
16. de Stancina, E., M. E. McCurrach, F. Zindy, S. Y. Shieh, G. Ferbeyre, A. V. Samuelson, C. Prives, M. F. Roussel, C. J. Sherr, and S. W. Lowe. 1998. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12: 2434-2442.
17. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
18. Eckner, R. 1996. p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol. Chem. 377:685-688.
19. Eckner, R., T. P. Yao, E. Oldread, and D. M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478-2490.
20. Fernandes, E. R., and R. J. Rooney. 1997. The adenovirus E1A-regulated transcription factor E4F is generated from the human homolog of nuclear factor φAP3. Mol. Cell. Biol. 17:1890-1903.
21. WAFI. Mol. Cell. Biol. 18:459-467.
22. Frisch, S. M. 1996. Reversal of malignancy by the adenovirus E1a gene. Mutat. Res. 350:261-266.
23. Frisch, S. M., and K. E. Dolter. 1995. Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism. Cancer Res. 55: 5551-5555.
24. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
25. Frisch, S. M., and E. Ruoslahti. 1997. Integrins and anoikis. Curr. Opin. Cell Biol. 9:701-706.
26. Gopalakrishnan, S., J. L. Douglas, and M. P. Quinlan. 1997. Immortalization of primary epithelial cells by E1A 12S requires late, second exonencoded functions in addition to complex formation with pRB and p300. Cell Growth Differ. 8:541-551.
27. Grossman, S. R., M. Perez, A. L. Kuang, M. Joseph, C. Mansur, Z. X. Xiao, S. Kumar, P. M. Howley, and D. M. Livingslon. 1998. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2:405-415.
28. Gunning, P., J. Leavitt, G. Muscat, S.-Y. Ng, and L. Kedes. 1987. A human beta-actin expression vector system directs high-level accumulation of anti-sense transcripts. Proc. Natl. Acad. Sci. USA 84:4831-4835.
29. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Hasegawa, K., M. B. Meyers, and R. N. Kitsis. 1997. Transcriptional coactivator p300 stimulates cell type-specific gene expression in cardiac myocytes. J. Biol. Chem. 272:20049-20054.
31. Hirsch, T., D. Decaudin, S. A. Susin, P. Marchetti, N. Larochette, M. Resche-Rigon, and G. Kroemer. 1998. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res. 241:426-434.
32. Hirsch, T., P. Marchetti, S. A. Susin, B. Dallaporta, N. Zamzami, I. Marzo, M. Geuskens, and G. Kroemer. 1997. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochrondrial permeability transition determine the mode of cell death. Oncogene 15:1753-1581.
33. Hirsch, T., I. Marzo, and G. Kroemer. 1997. Role of the mitochrondrial permeability transition pore in apoptosis. Biosci. Rep. 17:67-76.
34. Honda, R., and H. Yasuda. 1999. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18: 22-27.
35. Kamijo, T., J. D. Weber, G. Zambetti, F. Zindy, M. F. Roussel, and C. J. Sherr. 1998. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95:8292-8297.
36. Kawasaki, H., J. Song, R. Eckner, H. Ugai, R. Chiu, K. Taira, V. Shi, N. Jones, and K. K. Yokoyama. 1998. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12:233-245.
37. Kirshenbaum, L. A., and M. D. Schneider. 1995. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J. Biol. Chem. 270:7791-7794.
38. Krishan, A. 1975. A rapid flow cytometric analysis of the mammalian cell cycle by propidium iodide staining. J. Cell. Biol. 44:188-193.
39. Kroemer, G., B. Dallaporta, and M. Resche-Rigon. 1998. The mitochrondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619-42:619-642.
40. Lemasters, J. J., A. L. Nieminen, T. Qian, L. C. Trost, S. P. Elmore, Y. Nishimura, R. A. Crowe, W. E. Cascio, C. A. Bradham, D. A. Brenner, and B. Herman. 1998. The mitochrondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366:177-196.
41. Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams, and J. R. Nevins. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120-2130.
42. Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
43. Lin, H. J., V. Eviner, G. C. Prendergast, and E. White. 1995. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 15:4536-4544.
44. Linder, S., P. Popowicz, C. Svensson, M. Marshall, M. Bondesson, and G. Akusjarvi. 1992. Enhanced invasive properties of rat embryo fibroblasts transformed by adenovirus E1A mutants with deletions in the carboxyterminal exon. Oncogene 7:439-443.
45. Low, S. W., T. Jacks, D. E. Housman, and H. E. Ruley. 1994. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA 91:2026-2030.
46. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
47. Mal, A., R. Y. Poon, P. H. Howe, H. Toyoshima, T. Hunter, and M. L. Harter. 1996. Inactivation of p27Kep1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature 380:262-265.
48. Martin, S. J., C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-155.
49. Marzo, I., C. Brenner, N. Zamzami, J. M. Jurgensmeier, S. A. Susin, H. L. Vieira, M. C. Prevost, Z. Xie, S. Matsuyama, J. C. Reed, and G. Kroemer. 1998. Bax and adenine nucleotide translocator cooperate in the mitochrondiral control of apoptosis. Science 281:2027-2031.
50. McGill, G., A. Shimamura, R. C. Bates, R. E. Savage, and D. E. Fisher. 1997. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J. Cell Biol. 138:901-911.
51. Nevins, J. R. 1995. Adenovirus E1A: transcription regulation and alteration of cell growth control. Curr. Top. Microbiol. Immunol. 199:25-32.
52. Nevins, J. R., G. Leone, J. DeGregori, and L. Jakoi. 1997. Role of the Rb/E2F pathway in cell growth control. J. Cell Physiol. 173:233-236.
53. Ohtani, K., J. DeGregori, G. Leone, D. R. Herendeen, T. J. Kelly, and J. R. Nevins. 1996. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol. Cell. Biol. 16:6977-6984.
54. Persons, D. A., M. G. Mehaffey, M. Kaleko, A. W. Nienhuis, and E. F. Vanin. 1998. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24:167-182.
55. Pomerantz, J., N. Schreiber-Agus, N. J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H. W. Lee, C. Cordon-Cardo, and R. A. DePinho. 1998. The Ink4a tumor suppressor gene product, p19Arf, interaas with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-723.
56. Pozzatti, R., M. McCormack, M. A. Thompson, and G. Khoury. 1988. The E1a gene of adenovinis type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol. Biol. Cell 8:2984-2988.
57. Puri, P. L., M. L. Avantaggiati, C. Balsano, M. Sang, A. Graessmann, A. Giordano, and M. Levrero. 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:369-383.
58. Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1994. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
59. Rao, I., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Sci. USA 89:7742-7746. (Erratum, 89:9974.)
60. Rooney, R. J. Unpublished data.
61. Rooney, R. J., R. R, Daniels, N. A. Jenkins, D. J. Gilbert, K. Rothammer, S. W. Morris, D. R. Higgs, and N. G. Copeland. 1998. Chromosomal location and tissue expression of the gene encoding the adenovirus E1A-regulated transcription factor E4F in humans and mice. Mamm. Genome 9:320-323.
62. Rooney, R. J., P. Raychaudhuri, and J. R. Nevins. 1990. E4F and ATF, two transcription factors that recognize the same site, can be distinguished both physically and functionally: a role for E4F in E1A trans activation. Mol. Cell. Biol. 10:5138-5149.
63. Rooney, R. J., K. Rothammer, and E. R. Fernandes. 1998. Mutational analysis of p50E4F suggests that DNA binding activity is mediated through an alternative structure in a zinc finger domain that is regulated by phosphorylation. Nucleic Acids Res. 26:1681-1688.
64. Santos, E., S. R. Tronick, S. A. Aaronson, S. Pulcianni, and M. Barbacid. 1982. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB and Harvey-MSV transforming genes. Nature 298:343-347. (Abstract.)
65. Schmid, I., W. J. Krall, C. H. Uittenbogaart, J. Braun, and J. V. Giorgi. 1992. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13:204-208.
66. Schmid, I., C. H. Uittenbogaart, and J. V. Giorgi. 1994. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry 15:12-20.
67. Shisler, J., P. Duerksen-Hughes, T. M. Herminston, W. S. Wold, and L. R. Gooding. 1996. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70:68-77.
68. Somasundaram, K, and W. S. el-Dciry. 1997. Inhibition of pS3-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14:1047-1057.
69. Susin, S. A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochrondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.
70. Taylor, D. A., V. B. Kraus, J. J. Schwarz, E. N. Olsen, and W. E. Kraus. 1993. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol. Cell. Biol. 13:4714-4727.
71. van Engeland, M., L. J. Nieland, F. C. Ramaekers, B. Schutte, and C. P. Reutelingsperger. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9.
72. Verems, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39-51.
73. Weigel, R. J., S. H. Devote, and J. R. Nevins. 1990. Adenovirus 12S E1A gene represses differentiation of F9 tetratocarcinoma cells. Proc. Natl. Acad. Sci. USA 87:9878-9882.
74. White, E. 1995. Regulation of p53-dependent apoptosis by E1A and E1B. Curr. Top. Microbiol. Immunol. 199:34-58.
75. Yan, Z., J. DeGregori, R. Shohet, G. Leone, B. Stillman, J. R. Nevins, and R. S. Williams. 1998. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl. Acad. Sci. USA 95:3603-3608.
76. Yu, D., K. Scorsone, and M. C. Hung. 1991. Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogenes. Mol. Biol. Cell 11:1745-1750.
77. Yu, D., D. Shi, M. Scanlon, and M. C. Hung. 1993. Reexpression of neuencoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A. Cancer Res. 53:5784-5790.
78. Yuan, W., G. Condorelli, M. Caruso, A, Felsani, and A. Giordano. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:9009-9013.
79. Zamzami, N., T. Hirsch, B. Dallaporta, P. X. Petit, and G. Kroemer. 1997. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29:185-193.
80. Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. MyC signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12: 2424-2433.